Literature DB >> 1962742

One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies.

S Kodama1, E Uchijima, M Nagai, K Mikawatani, T Hayashi, K Suzuki.   

Abstract

Six monoclonal antibodies for human thrombomodulin (TM) were prepared. All of them recognized an elastase-digested fragment of TM which contains 6 epidermal growth factor (EGF)-like structural domains. We developed a one-step sandwich enzyme immunoassay for soluble TM by using 2 antibodies; one of them, which inhibited thrombin-binding to TM, was fixed to polystyrene balls, and the other, which did not inhibit the thrombin-binding, but inhibited the protein C-activating cofactor activity of TM, was used as peroxidase-labeled conjugate. The sensitivity of this assay was 1 microgram/l for soluble TM. The level of soluble TM was found to be significantly increased in sera of patients with systemic lupus erythematosus in comparison to the level in sera of healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1962742     DOI: 10.1016/0009-8981(90)90221-d

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.

Authors:  Masahiko Okada; Norio Tominaga; Goichi Honda; Junji Nishioka; Nobuyuki Akita; Tatsuya Hayashi; Koji Suzuki; Hiroyuki Moriuchi
Journal:  Blood Adv       Date:  2020-06-23

2.  Effect of a prostaglandin I(2) analog on the expression of thrombomodulin in liver and spleen endothelial cells after an extensive hepatectomy.

Authors:  Masanobu Usui; Hiroyuki Kato; Naohisa Kuriyama; Yoshinori Azumi; Masashi Kishiwada; Shugo Mizuno; Hiroyuki Sakurai; Masami Tabata; Tatsuya Hayashi; Koji Suzuki; Shuji Isaji
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

3.  Release of thrombomodulin from endothelial cells by concerted action of TNF-alpha and neutrophils: in vivo and in vitro studies.

Authors:  M W Boehme; Y Deng; U Raeth; A Bierhaus; R Ziegler; W Stremmel; P P Nawroth
Journal:  Immunology       Date:  1996-01       Impact factor: 7.397

4.  Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure.

Authors:  T Iba; Y Yagi; A Kidokoro; M Fukunaga; T Fukunaga
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

5.  Plasma endothelin-1 concentrations are elevated in acute hepatitis and liver cirrhosis but not in chronic hepatitis.

Authors:  Y Uchida; M Watanabe
Journal:  Gastroenterol Jpn       Date:  1993-10

6.  Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura.

Authors:  M Fujieda; N Oishi; K Naruse; M Hashizume; K Nishiya; T Kurashige; K Ito
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

7.  Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases.

Authors:  A M Sawyerr; M S Smith; A Hall; M Hudson; C R Hay; A J Wakefield; M G Brook; H Tomura; R E Pounder
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

8.  Decreased plasma soluble thrombomodulin levels as a risk factor for pulmonary thromboembolism.

Authors:  Yu-Dong Yin; Chen Wang; Zhen-Guo Zhai; Bao-Sen Pang; Yuan-Hua Yang; Xiu-Xia Huang
Journal:  J Thromb Thrombolysis       Date:  2008-03-31       Impact factor: 2.300

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.